Ibrance(palbociclib) Side Effects

The undesirable effects associated with the drug.

Adverse Reactions

The most common adverse reactions include hematologic toxicities such as neutropenia, leukopenia, anemia, and thrombocytopenia. Other frequent side effects comprise infections, fatigue, nausea, stomatitis, diarrhea, alopecia, and elevated liver enzymes. When used in the triplet regimen with inavolisib and fulvestrant, additional common reactions include hyperglycemia, rash, decreased appetite, and electrolyte imbalances. Severe side effects can include febrile neutropenia and interstitial lung disease/pneumonitis.

palbociclib(Ibrance)
Treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with endocrine therapy or targeted agents.
RELATED ARTICLES
/ 0
0 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved